SE312554B - - Google Patents
Info
- Publication number
- SE312554B SE312554B SE7677/64A SE767764A SE312554B SE 312554 B SE312554 B SE 312554B SE 7677/64 A SE7677/64 A SE 7677/64A SE 767764 A SE767764 A SE 767764A SE 312554 B SE312554 B SE 312554B
- Authority
- SE
- Sweden
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH851363A CH433275A (de) | 1963-07-09 | 1963-07-09 | Verfahren zur Herstellung von 19-Alkylsteroiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE312554B true SE312554B (de) | 1969-07-21 |
Family
ID=4341402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7677/64A SE312554B (de) | 1963-07-09 | 1964-06-24 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3309387A (de) |
| BE (1) | BE650260A (de) |
| BR (1) | BR6460648D0 (de) |
| CH (1) | CH433275A (de) |
| DE (1) | DE1468035C3 (de) |
| DK (1) | DK115400B (de) |
| ES (1) | ES301833A1 (de) |
| GB (1) | GB1040554A (de) |
| NL (1) | NL6406879A (de) |
| SE (1) | SE312554B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH464189A (de) * | 1966-04-20 | 1968-10-31 | Hoffmann La Roche | Verfahren zur Herstellung von 19-Alkenylsteroiden |
| US3859272A (en) * | 1968-07-23 | 1975-01-07 | Hoechst Ag | 19-alkylene-14- ' -hydroxy-cardenolide derivatives and process for preparing them |
| US4139617A (en) * | 1974-05-13 | 1979-02-13 | Richardson-Merrell Inc. | 19-Oxygenated-androst-5-enes for the enhancement of libido |
| WO2005020928A2 (en) * | 2003-08-29 | 2005-03-10 | The Regents Of The University Of California | Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins |
| CN1882606A (zh) * | 2003-11-24 | 2006-12-20 | 默克公司 | ***受体调节剂 |
| US20080015173A1 (en) * | 2004-06-10 | 2008-01-17 | Blizzard Timothy A | Estrogen Receptor Modulators |
| WO2006012333A1 (en) * | 2004-06-30 | 2006-02-02 | Merck & Co., Inc. | Estrogen receptor modulators |
| AU2007217366A1 (en) * | 2006-02-27 | 2007-08-30 | The Regents Of The University Of California | Oxysterol compounds and the hedgehog pathway |
| EP2231164A1 (de) * | 2007-12-03 | 2010-09-29 | The Regents of the University of California | Oxysterole zur aktivierung von hedgehog-signalisierung, osteoinduktion, antiadipogenese und wnt-signalisierung |
| JP6262723B2 (ja) | 2012-05-07 | 2018-01-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ | オキシステロールアナログｏｘｙ１３３は、骨発生及びヘッジホッグシグナル伝達を誘導し、脂肪生成を阻害する |
| CN105263500A (zh) | 2013-05-02 | 2016-01-20 | 加利福尼亚大学董事会 | 骨选择性成骨性氧固醇-骨靶向剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2844603A (en) * | 1955-07-05 | 1958-07-22 | Searle & Co | Process for oxidation of steroids with peroxytrifluoroacetic acid |
| NL286295A (de) * | 1961-12-04 | |||
| NL292848A (de) * | 1962-05-16 | |||
| US3102127A (en) * | 1962-06-12 | 1963-08-27 | Syntex Corp | 19-methylene-androstane derivatives |
| US3206458A (en) * | 1962-06-12 | 1965-09-14 | Syntex Corp | 19-substituted pregnenes |
-
1963
- 1963-07-09 CH CH851363A patent/CH433275A/de unknown
-
1964
- 1964-06-02 DE DE1468035A patent/DE1468035C3/de not_active Expired
- 1964-06-17 NL NL6406879A patent/NL6406879A/xx unknown
- 1964-06-24 SE SE7677/64A patent/SE312554B/xx unknown
- 1964-07-01 US US379709A patent/US3309387A/en not_active Expired - Lifetime
- 1964-07-07 BR BR160648/64A patent/BR6460648D0/pt unknown
- 1964-07-08 BE BE650260D patent/BE650260A/xx unknown
- 1964-07-08 ES ES301833A patent/ES301833A1/es not_active Expired
- 1964-07-09 DK DK344764AA patent/DK115400B/da unknown
- 1964-07-09 GB GB28370/64A patent/GB1040554A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1040554A (en) | 1966-09-01 |
| BR6460648D0 (pt) | 1973-12-26 |
| DE1468035C3 (de) | 1974-03-21 |
| CH433275A (de) | 1967-04-15 |
| US3309387A (en) | 1967-03-14 |
| BE650260A (de) | 1965-01-08 |
| NL6406879A (de) | 1965-01-11 |
| DE1468035B2 (de) | 1973-08-02 |
| ES301833A1 (es) | 1962-12-16 |
| DE1468035A1 (de) | 1968-12-12 |
| DK115400B (da) | 1969-10-06 |